Skip to contentHedley Mary Lynne — VEEVA SYSTEMS INC insider: 207 transactions · InsiderLensHedley Mary Lynne
- Director at Centessa Pharmaceuticals plc · on record since May 27, 2021
- Executive VP of Ops & CSO at New Abraxis, Inc. · on record since Jul 15, 2009
- Director at TESARO, Inc. · on record since Jun 27, 2012
- Director at VEEVA SYSTEMS INC · on record since Jun 3, 2026
- Director at Receptos, Inc. · on record since Apr 14, 2014
- President & COO at TESARO, Inc. · on record since Mar 3, 2017
- Director at BLUE HOLDINGS, INC. · on record since Sep 20, 2017
- Director at Tempest Therapeutics, Inc. · on record since Dec 11, 2018
- Director at LILLY ELI & CO · on record since Jun 22, 2022
- Sr. VP & Chief Scientific Off at MGI PHARMA INC · on record since Oct 6, 2005
Insider trading activity of Hedley Mary Lynne
- Transactions on record
- 207
- since Jul 17, 2006
- Open-market buys
- 0
- Open-market sells
- 9
- $1.1M
- Companies traded
- 9
- last filing Jun 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where Hedley Mary Lynne has traded
- Centessa Pharmaceuticals plc9 tx · Jun 24, 2026
- VEEVA SYSTEMS INC80 tx · $146.4K · Jun 22, 2026
- LILLY ELI & CO48 tx · $1.2M · Dec 16, 2025
- Tempest Therapeutics, Inc.4 tx · Jun 23, 2020
- TESARO, Inc.36 tx · $46.2M · Jan 22, 2019
- BLUE HOLDINGS, INC.4 tx · Jun 22, 2018
- Receptos, Inc.6 tx · $3.9M · Aug 27, 2015
- New Abraxis, Inc.2 tx · Jul 15, 2009
- MGI PHARMA INC18 tx · $9.5M · Jan 30, 2008
Track record of Hedley Mary Lynne
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Hedley Mary Lynne
Co-insiders of Hedley Mary Lynne
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BASKETT FORESTTempest Therapeutics, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 24, 2026 | OtherD | -48,000 | — | — | SEC |
| Jun 24, 2026 | OtherD | -40,000 | — | — | SEC |
| Jun 24, 2026 | OtherD | -48,000 | — | — | SEC |
| Jun 24, 2026 | OtherD | -48,000 | — | — | SEC |
| Jun 24, 2026 | OtherD | -208,474 | — | — | SEC |
| Jun 22, 2026 | AwardD | 1,906 | 0.00 USD | — | SEC |
| Jun 3, 2026 | Exercise | 262 | 0.00 USD | $0 | SEC |
| Jun 3, 2026 | ExerciseD | -262 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | Exercise | 262 | 0.00 USD | $0 | SEC |
| Mar 3, 2026 | ExerciseD | -262 | 0.00 USD | $0 | SEC |
| Dec 16, 2025 | Award | 9.34 | 1,062.19 USD | $9.9K | SEC |
| Dec 2, 2025 | Exercise | 263 | 0.00 USD | $0 | SEC |
| Dec 2, 2025 | ExerciseD | -263 | 0.00 USD | $0 | SEC |
| Nov 18, 2025 | Award | 9.71 | 1,021.70 USD | $9.9K | SEC |
| Nov 18, 2025 | Award | 215.33 | 1,021.70 USD | $220K | SEC |
| Oct 22, 2025 | Award | 12.26 | 808.96 USD | $9.9K | SEC |
| Sep 17, 2025 | Award | 13.25 | 748.19 USD | $9.9K | SEC |
| Sep 3, 2025 | ExerciseD | -262 | 0.00 USD | $0 | SEC |
| Sep 3, 2025 | Exercise | 262 | 0.00 USD | $0 | SEC |
| Aug 19, 2025 | Award | 14.21 | 698.05 USD | $9.9K | SEC |
| Jul 22, 2025 | Award | 13.01 | 762.18 USD | $9.9K | SEC |
| Jun 24, 2025 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 1,049 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | Award | 12.28 | 807.58 USD | $9.9K | SEC |
| Jun 2, 2025 | ExerciseD | -343 | 0.00 USD | $0 | SEC |